Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry
Author:
Breidbart Emily1, Deng Liyong2, Lanzano Patricia2, Fan Xiao2, Guo Jiancheng2, Leibel Rudolph L.2, LeDuc Charles A.2, Chung Wendy K.2
Affiliation:
1. Department of Pediatrics , Division of Pediatric Endocrinology and Diabetes, NYU School of Medicine , New York , NY, USA 2. Department of Pediatrics , Division of Molecular Genetics, Columbia University Medical Center , New York , NY, USA
Abstract
Abstract
Objectives
There have been few large-scale studies utilizing exome sequencing for genetically undiagnosed maturity onset diabetes of the young (MODY), a monogenic form of diabetes that is under-recognized. We describe a cohort of 160 individuals with suspected monogenic diabetes who were genetically assessed for mutations in genes known to cause MODY.
Methods
We used a tiered testing approach focusing initially on GCK and HNF1A and then expanding to exome sequencing for those individuals without identified mutations in GCK or HNF1A. The average age of onset of hyperglycemia or diabetes diagnosis was 19 years (median 14 years) with an average HbA1C of 7.1%.
Results
Sixty (37.5%) probands had heterozygous likely pathogenic/pathogenic variants in one of the MODY genes, 90% of which were in GCK or HNF1A. Less frequently, mutations were identified in PDX1, HNF4A, HNF1B, and KCNJ11. For those probands with available family members, 100% of the variants segregated with diabetes in the family. Cascade genetic testing in families identified 75 additional family members with a familial MODY mutation.
Conclusions
Our study is one of the largest and most ethnically diverse studies using exome sequencing to assess MODY genes. Tiered testing is an effective strategy to genetically diagnose atypical diabetes, and familial cascade genetic testing identified on average one additional family member with monogenic diabetes for each mutation identified in a proband.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health
Reference39 articles.
1. Hattersley, A, Greeley, S, Polak, M, Rubio-Cabezas, O, Njølstad, P, Mlynarski, W, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2018;19:47–63. 2. Naylor, R, Philipson, L. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol 2011;75:422–6. 3. Kavvoura, FK, Owen, KR. Maturity onset diabetes of the young: clinical characteristics, diagnosis and management. Pediatr Endocrinol Rev 2012;10:234–42. 4. Gat-Yablonski, G, Shalitin, S, Phillip, M. Maturity onset diabetes of the young—review. Pediatr Endocrinol Rev 2006;3:514–20. 5. Thanabalasingham, G, Pal, A, Selwood, MP, Dudley, C, Fisher, K, Bingley, PJ, et al.. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 2012;35:1206–12.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|